Tennessee SB 709: Drugs, Prescription - As enacted, requires the commissioners of health and mental health and substance abuse services to produce guidelines on nonresidential buprenorphine treatment by January 1, 2018, and to annually update those guidelines. - Amends TCA Title 63, Chapter 1.

Status: Comp. became Pub. Ch. 112 (as of 2017-04-19)

State: Tennessee · Session: 110 · Bill: SB 709

Subjects: Drugs, Prescription

Sponsors: Powers, Yager

View Tennessee SB 709 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.